Manulife (Manufacturers Life Insurance)’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $606K | Buy |
52,308
+37,024
| +242% | +$429K | ﹤0.01% | 2080 |
|
2025
Q1 | $133K | Sell |
15,284
-73,536
| -83% | -$642K | ﹤0.01% | 2620 |
|
2024
Q4 | $1.28M | Sell |
88,820
-42,950
| -33% | -$617K | ﹤0.01% | 1782 |
|
2024
Q3 | $2.98M | Sell |
131,770
-10,053
| -7% | -$227K | ﹤0.01% | 1411 |
|
2024
Q2 | $2.76M | Sell |
141,823
-15,092
| -10% | -$294K | ﹤0.01% | 1395 |
|
2024
Q1 | $5.89M | Buy |
156,915
+42,869
| +38% | +$1.61M | 0.01% | 1114 |
|
2023
Q4 | $6.38M | Buy |
114,046
+16,019
| +16% | +$896K | ﹤0.01% | 1055 |
|
2023
Q3 | $4.04M | Buy |
98,027
+21,524
| +28% | +$888K | ﹤0.01% | 1202 |
|
2023
Q2 | $4.27M | Sell |
76,503
-4,811
| -6% | -$269K | ﹤0.01% | 1159 |
|
2023
Q1 | $4.54M | Sell |
81,314
-5,456
| -6% | -$304K | ﹤0.01% | 1131 |
|
2022
Q4 | $3.18M | Sell |
86,770
-5,466
| -6% | -$200K | ﹤0.01% | 1255 |
|
2022
Q3 | $2.76M | Buy |
92,236
+50,823
| +123% | +$1.52M | ﹤0.01% | 1295 |
|
2022
Q2 | $1.91M | Buy |
41,413
+9,194
| +29% | +$424K | ﹤0.01% | 1435 |
|
2022
Q1 | $2.41M | Buy |
32,219
+30,230
| +1,520% | +$2.26M | ﹤0.01% | 1454 |
|
2021
Q4 | $300 | Sell |
1,989
-20
| -1% | -$3 | ﹤0.01% | 2603 |
|
2021
Q3 | $292K | Sell |
2,009
-63,002
| -97% | -$9.16M | ﹤0.01% | 2690 |
|
2021
Q2 | $12.7M | Buy |
65,011
+437
| +0.7% | +$85.6K | 0.01% | 863 |
|
2021
Q1 | $11.7M | Buy |
64,574
+132
| +0.2% | +$23.9K | 0.01% | 882 |
|
2020
Q4 | $9.13M | Buy |
64,442
+52,166
| +425% | +$7.39M | 0.01% | 942 |
|
2020
Q3 | $1.53M | Buy |
+12,276
| New | +$1.53M | ﹤0.01% | 1505 |
|